Target
Serine/threonine-protein kinase B-raf [416-766,V600E]
Ligand
BDBM313307
Substrate
n/a
Meas. Tech.
In Vitro Raf Activity Determination
IC50
446±n/a nM
Citation
 Aversa, RJBurger, MTDillon, MPDineen, Jr., TALou, YNishiguchi, GARamurthy, SRico, ACRauniyar, VSendzik, MSubramanian, SSetti, LQTaft, BRTanner, HRWan, L Compounds and compositions as RAF kinase inhibitors US Patent  US10167279 Publication Date 1/1/2019 
Target
Name:
Serine/threonine-protein kinase B-raf [416-766,V600E]
Synonyms:
B-Raf (V600E) | BRAF | BRAF1 | BRAF_HUMAN | RAFB1
Type:
n/a
Mol. Mass.:
39690.71
Organism:
Homo sapiens (Human)
Description:
PV3849, from Invitrogen
Residue:
351
Sequence:
LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH
  
Inhibitor
Name:
BDBM313307
Synonyms:
2-(2-cyanopropan-2-yl)- N-(3-(6-ethoxy-5-(3- (fluoromethyl)oxetan-3- yl)pyridin-3-yl)-4- methylphenyl)isonicotin- amide | US10167279, Example 31
Type:
Small organic molecule
Emp. Form.:
C28H29FN4O3
Mol. Mass.:
488.5533
SMILES:
CCOc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C
Structure:
Search PDB for entries with ligand similarity: